Insider · CIK 0001817217
Hans van Houte
cfoofficer
Files at NRIX (Nurix Therapeutics, Inc.). First filing Oct 30, 2024, latest Aug 1, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 6
$0 bought, $353k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
NRIX: Nurix Therapeutics, Inc.
NRIXOct 9, 2026 · close 22.35
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 29Weak | Nurix Therapeutics, Inc. | $60k 5,402 shares | -13% | +25% from low-61% from high | |
| 29Weak | Nurix Therapeutics, Inc. | $52k 4,304 shares | -10% | +35% from low-58% from high | |
| 30Weak | Nurix Therapeutics, Inc. | $70k 6,198 shares | -16% | +28% from low-60% from high | |
| 27Weak | Nurix Therapeutics, Inc. | $28k 2,438 shares | -6% | +31% from low-59% from high | |
| 26Weak | Nurix Therapeutics, Inc. | $86k 3,546 shares | -10% | - | |
| 29Weak | Nurix Therapeutics, Inc. | $58k 2,368 shares | -6% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 1, 2025 | NRIX Nurix Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -5,402 | $11.03 | $60k | 35,512 | Aug 1, 2025 |
| Jul 30, 2025 | NRIX Nurix Therapeutics, Inc. | MOption exercise Common Stock | +2,886 | $0.00 | $0 | 36,610 | Jul 30, 2025 |
| Jul 30, 2025 | NRIX Nurix Therapeutics, Inc. | MOption exercise Common Stock | +2,000 | $0.00 | $0 | 38,610 | Jul 30, 2025 |
| Jul 30, 2025 | NRIX Nurix Therapeutics, Inc. | MOption exercise Common Stock | +3,750 | $0.00 | $0 | 42,360 | Jul 30, 2025 |
| Jul 30, 2025 | NRIX Nurix Therapeutics, Inc. | MOption exercise Common Stock | +2,858 | $0.00 | $0 | 45,218 | Jul 30, 2025 |
| Jul 30, 2025 | NRIX Nurix Therapeutics, Inc. | SOpen-market sale Common Stock | -4,304 | $12.01 | $52k | 40,914 | Jul 30, 2025 |
| Jul 30, 2025 | NRIX Nurix Therapeutics, Inc. | MOption exercise Restricted Stock Unitsderivative | -2,886 | $0.00 | $0 | 5,773 | Jul 30, 2025 |
| Jul 30, 2025 | NRIX Nurix Therapeutics, Inc. | MOption exercise Restricted Stock Unitsderivative | -2,000 | $0.00 | $0 | 6,000 | Jul 30, 2025 |
| Jul 30, 2025 | NRIX Nurix Therapeutics, Inc. | MOption exercise Restricted Stock Unitsderivative | -3,750 | $0.00 | $0 | 26,250 | Jul 30, 2025 |
| Jul 30, 2025 | NRIX Nurix Therapeutics, Inc. | MOption exercise Restricted Stock Unitsderivative | -2,858 | $0.00 | $0 | 31,442 | Jul 30, 2025 |
| May 2, 2025 | NRIX Nurix Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -6,198 | $11.33 | $70k | 33,724 | May 2, 2025 |
| Apr 30, 2025 | NRIX Nurix Therapeutics, Inc. | MOption exercise Common Stock | +2,886 | $0.00 | $0 | 36,610 | Apr 30, 2025 |
| Apr 30, 2025 | NRIX Nurix Therapeutics, Inc. | MOption exercise Common Stock | +2,000 | $0.00 | $0 | 38,610 | Apr 30, 2025 |
| Apr 30, 2025 | NRIX Nurix Therapeutics, Inc. | MOption exercise Common Stock | +3,750 | $0.00 | $0 | 42,360 | Apr 30, 2025 |
| Apr 30, 2025 | NRIX Nurix Therapeutics, Inc. | SOpen-market sale Common Stock | -2,438 | $11.50 | $28k | 39,922 | Apr 30, 2025 |
| Apr 30, 2025 | NRIX Nurix Therapeutics, Inc. | MOption exercise Restricted Stock Unitsderivative | -2,886 | $0.00 | $0 | 8,659 | Apr 30, 2025 |
| Apr 30, 2025 | NRIX Nurix Therapeutics, Inc. | MOption exercise Restricted Stock Unitsderivative | -2,000 | $0.00 | $0 | 8,000 | Apr 30, 2025 |
| Apr 30, 2025 | NRIX Nurix Therapeutics, Inc. | MOption exercise Restricted Stock Unitsderivative | -3,750 | $0.00 | $0 | 30,000 | Apr 30, 2025 |
| Nov 1, 2024 | NRIX Nurix Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -3,546 | $24.28 | $86k | 33,724 | Nov 1, 2024 |
| Oct 30, 2024 | NRIX Nurix Therapeutics, Inc. | MOption exercise Common Stock | +2,886 | $0.00 | $0 | 33,888 | Oct 30, 2024 |
| Oct 30, 2024 | NRIX Nurix Therapeutics, Inc. | MOption exercise Common Stock | +2,000 | $0.00 | $0 | 35,888 | Oct 30, 2024 |
| Oct 30, 2024 | NRIX Nurix Therapeutics, Inc. | MOption exercise Common Stock | +3,750 | $0.00 | $0 | 39,638 | Oct 30, 2024 |
| Oct 30, 2024 | NRIX Nurix Therapeutics, Inc. | SOpen-market sale Common Stock | -2,368 | $24.31 | $58k | 37,270 | Oct 30, 2024 |
| Oct 30, 2024 | NRIX Nurix Therapeutics, Inc. | MOption exercise Restricted Stock Unitsderivative | -2,886 | $0.00 | $0 | 14,431 | Oct 30, 2024 |
| Oct 30, 2024 | NRIX Nurix Therapeutics, Inc. | MOption exercise Restricted Stock Unitsderivative | -2,000 | $0.00 | $0 | 12,000 | Oct 30, 2024 |
| Oct 30, 2024 | NRIX Nurix Therapeutics, Inc. | MOption exercise Restricted Stock Unitsderivative | -3,750 | $0.00 | $0 | 37,500 | Oct 30, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.